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There has been a move away from vaccines composed of whole or inactivated anti-
gens toward subunit-based vaccines, which although safe, provide less immunological 
protection. As a result, the use of adjuvants to enhance and direct adaptive immune 
responses has become the focus of much targeted bovine vaccine research. However, 
the mechanisms by which adjuvants work to enhance immunological protection in many 
cases remains unclear, although this knowledge is critical to the rational design of effec-
tive next generation vaccines. This study aimed to investigate the mechanisms by which 
alum, a commonly used adjuvant in bovine vaccines, enhances IL-1β secretion in bovine 
peripheral blood mononuclear cells (PBMCs). Unlike the case with human PBMCs, alum 
promoted IL-1β secretion in a subset of bovine PBMCs without priming with a toll-like 
receptor agonist. This suggests that PBMCs from some cattle are primed to produce this 
potent inflammatory cytokine and western blotting confirmed the presence of preexisting 
pro-IL-1β in PBMCs from a subset of 8-month-old cattle. To address the mechanism 
underlying alum-induced IL-1β secretion, specific inhibitors identified that alum mediates 
lysosomal disruption which subsequently activates the assembly of an NLRP3, ASC, 
caspase-1, and potentially caspase-8 containing complex. These components form an 
inflammasome, which mediates alum-induced IL-1β secretion in bovine PBMCs. Given 
the demonstrated role of the NLRP3 inflammasome in regulating adaptive immunity in 
murine systems, these results will inform further targeted research into the potential of 
inflammasome activation for rational vaccine design in cattle.
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inTrODUcTiOn
IL-1β, a member of the IL-1 cytokine family, is an inflammatory cytokine that mediates an array 
of effector functions including vasodilation, inflammatory cell infiltration, and adhesion molecule 
expression (1). Primarily produced by monocytes, macrophages, and dendritic cells, IL-1β synthesis 
and secretion is tightly regulated. It requires a signal (“signal 1”), generally in the form of a pathogen-
associated molecular pattern (PAMP) or endogenous danger signal to induce the expression of pro-
IL-1β, followed by “signal 2” to activate caspase-1, which processes the cytokine into its active form 
(2, 3). The NLRP3 inflammasome, comprising NLRP3, ASC, and caspase-1, is the best characterized 
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inflammasome and can be activated by a range of stimuli includ-
ing uric acid, cholesterol crystals, ATP, silica, and asbestos (4). 
Additionally, in murine and human cells it has been shown that 
alum based adjuvants can activate the NLRP3 inflammasome and 
caspase-1, resulting in the secretion of bioactive IL-1β (5).
Presently, alum is one of a select few adjuvants approved for 
use in human and veterinary vaccines. Despite its widespread 
use, the immuno-modulatory properties of alum are not 
fully understood and have received little attention in a bovine 
context. Upon injection, alum recruits an array of innate cells 
including monocytes, dendritic cells, NK cells, and neutrophils 
(5–7). Additionally, alum injection triggers the production of 
numerous inflammatory cytokines and chemokines including 
IL-1β, IL-18, and keratinocyte chemoattractant (6, 8). In mice, 
it has been established that alum-induced IL-1β secretion is 
reduced in NLRP3 and caspase-1-deficient cells in vitro. Alum 
is an effective adjuvant at promoting antigen specific humoral 
immunity but has limited capacity to promote Th1 responses (6, 
9–11). As result, alum is not an optimal adjuvant for all vaccines. 
However, many of these findings are based on murine studies so 
understanding the mechanism by which alum enhances immune 
responses in a bovine context is important to advance bovine 
vaccine development.
Interindividual variation in responses to both antigens and 
adjuvants may contribute to suboptimal efficacy of a number 
of bovine vaccines. These systems may be developed in mouse 
models and are limited by the lack of a sufficiently detailed under-
standing of the bovine immune response and therefore often do 
not work well in cattle (12). Given the significant differences in 
innate immunity between species and the widespread use of alum 
as an adjuvant in cattle, it is therefore important to address the 
specific effects of alum in bovine cells.
MaTerials anD MeThODs
ethics statement
All animal procedures were carried out according to the provi-
sions of the EU Protection of Animals Used for Scientific Purposes 
Regulations 2012 (SI No. 543 of 2012) as amended and Directive 
2010/63/EU of the European Parliament issued from the Health 
Products Regulatory Authority Ireland—license number AE 
19132/P030. Human blood samples were collected from anony-
mous healthy blood donors from the Irish Blood Transfusion 
Service (IBTS) under license number (BI-AG-300919) issued 
from the School of Biochemistry and Immunology Research 
Ethics Committee, Trinity College Dublin in accordance with the 
Declaration of Helsinki.
animals
All animals used in this research project were healthy Holstein-
Friesian calves under 1 year old (unless stated). Buffy coats were 
collected from anonymous healthy human blood donors.
reagents
The stimuli used to activate cells were LPS, Escherichia coli Serotype 
R515 (Enzo Life Sciences) and alhydrogel (Brenntag Biosector). 
Inhibitory molecules used in this research included: MCC950 
(Cayman Chemical), caspase1-Z-YVAD-FMK (Bachem), cas-
pase8-Z-IETD-FMK (Bachem), CA-074 (Sigma-Aldrich), and 
cathepsinB-CA-074-Me (Sigma-Aldrich). Antibodies used for 
western blotting included: polyclonal anti bovine IL-1β (Bio-Rad), 
polyclonal (N-15-R) antimouse ASC (Santa Cruz Biotechnology 
sc-22514-R), and monoclonal (AC-74) β-actin (Sigma-Aldrich). 
ELISA kits used to detect bovine IL-1β and human IL-1β were 
sourced from ThermoScientific and R&D Systems, respectively. 
The FLICA™ Assay Kit (FAM-YVAD-FMK) for caspase-1 detec-
tion was acquired from ImmunoChemistry Technologies.
Peripheral Blood Mononuclear cell 
(PBMc) isolation and culture
Bovine PBMCs were isolated from whole blood samples collected 
in 9  ml vacutainers containing Heparin anticoagulant. Human 
PBMCS were extracted from buffy coats. PBMCs were isolated 
using leucosep tubes (Greiner Bio-One, Storehouse, UK) and a 
density gradient histopaque 1077 (Sigma-Aldrich). Red blood 
cell contamination was eliminated using sterile 0.25% sodium 
chloride (Baxter) as a lysis buffer. The cells were subsequently 
centrifuged twice in PBS at a speed of 400 g for 10 min. For innate 
cytokine analysis, cells were incubated at 37°C with 5% CO2 in 
RMPI 1640 medium (Biosera) enriched with heat-inactivated 
fetal calf serum (Biosera), l-glutamine (Gibco), and penicillin 
(Gibco).
elisa
Supernatants from treated cells were used to measure IL-1β secre-
tion by ELISA as per the manufacturer’s protocols. Absorbance 
was read on a Multiscan FC plate reader and analyzed with SkanIt 
for Multiscan FC software (Thermo Scientific). The limit of detec-
tion was between 31.25 and 2,000 pg/ml.
Western Blotting
Peripheral blood mononuclear cells were lysed using 100  µl of 
Laemmli buffer (4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 
0.004% bromophenol blue, 0.125 M Tris–HCl). The lysates were 
transferred onto a 0.2  µm PVDF membrane (Millipore) and 
probed with anti-IL-1β, anti-ASC, and anti-β-actin antibodies. 
The blots were developed using a Bio-Rad ChemiDoc Imaging 
system (Bio-Rad).
Flica™ assay
In preparation for caspase-1 analysis, cells were seeded at a density 
of 1 × 107/ml and incubated with stimuli. Following incubation, 
the cells were resuspended and then centrifuged at 1,200 rpm for 
5  min to pellet the cells. The supernatants were discarded and 
the cells were resuspended in FACs buffer (1% FCS in PBS) and 
incubated for 30 min with caspase-1 specific probe. The cells were 
centrifuged and washed three times in FACs buffer and analyzed 
by flow cytometry.
confocal Microscopy
Peripheral blood mononuclear cells (0.5  ×  106 cells/ml) were 
plated in cRPMI on 35 mm glass bottom tissue dishes. Cells were 
FigUre 1 | Alum enhances IL-1β secretion by bovine peripheral blood 
mononuclear cells (PBMCs). Cells (0.625 × 106 cells/ml) from three animals 
were stimulated with RPMI, LPS, and/or alum for 24 h and supernatants 
were tested for IL-1β using ELISA. PBMCs were primed with LPS (10 ng/ml) 
for 3 h before the cells were stimulated with alum (100 µg/ml) for 24 h (a). 
Cells were primed with concentrations of LPS ranging from 1 pg/ml to  
1 μg/ml and a fixed dose of alum (50 µg/ml) (B). PBMCs were primed with a 
single dose of LPS (100 pg/ml) and alum at a concentration of 25, 50, or 
100 µg/ml (c). For ELISA analysis, results are mean cytokine concentrations 
(+SEM) in supernatants that were tested individually in triplicate. *p < 0.05 
and **p < 0.01 were calculated using GraphPad.
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treated with alum (50 µg/ml), LPS (1 pg/ml), alum + LPS, and 
or RPMI only and stained with calcein as outlined by Khormaee 
et  al. (13). Cells were viewed using a Point Scanning Confocal 
Microscope with a heated stage and CO2 chamber (Olympus 
FV100 LSM Confocal Microscope).
statistics
Statistical analysis was performed using Graphpad Prism 5 soft-
ware. The means for two groups were compared using a paired 
T-test. The means for three or more groups were compared using 
one-way ANOVA. A p-value of <0.05 was taken as statistically 
significant.
resUlTs
alum Promotes il-1β secretion  
by Bovine PBMcs
It has been previously established in murine and human cells 
that a combination of LPS and alum effectively drives NLRP3 
inflammasome dependent IL-1β secretion (14), although this has 
not been investigated in cattle. Bovine PBMCs were isolated from 
Friesian calves (<6 months old) and treated with a range of LPS 
and alum concentrations for 24 h. Bovine PBMCs secreted small 
amounts of IL-1β in response to LPS (10  ng/ml) but secretion 
was significantly elevated when alum (100  µg/ml) was added 
(Figure 1A).
Incubation of PBMCs with a fixed dose of alum (50 µg/ml) and 
LPS concentrations from 1 pg/ml to 1 µg/ml resulted in higher 
IL-1β secretion than the corresponding amounts of LPS alone 
(Figure 1B). A surprising observation was that cells stimulated 
with alum in the absence of LPS secreted IL-1β (Figure  1B). 
This observation contrasts what is seen in murine and human 
macrophages and dendritic cells. A more detailed analysis found 
that addition of alum to cells at 25, 50, or 100 µg/ml enhanced 
IL-1β secretion from LPS-primed PBMCs (Figure  1C). To 
address whether the IL-1β promoting ability of alhydrogel also 
applied to aluminum phosphate and calcium phosphate, PBMCs 
were treated with these clinically applied adjuvants alone or fol-
lowing priming with LPS. As seen with alhydrogel, both calcium 
phosphate and aluminum phosphate were potent stimuli for 
promoting IL-1β secretion by bovine cells (Figures 2A,B).
PBMcs from a subset of calves contain 
Preformed PrO-il-1β
To secrete IL-1β, innate immune cells generally require two signals 
in the form of a PAMP agonist and an inflammasome activator 
(15, 16). Typically, toll-like receptor (TLR) agonists prime cells to 
synthesize inactive pro-IL-1β while activation of the inflamma-
some triggers caspase-1 activation and the cleavage and secretion 
of processed IL-1β. Given the remarkable observation that alum 
could trigger the secretion of IL-1β in the absence of priming with 
LPS (Figure  1B), it was hypothesized that PBMCs from some 
calves may contain preformed pro-IL-1β and as such require 
no TLR priming. To address this, PBMCs were isolated from 17 
calves (aged < 1 year old) and were treated with LPS, alum or a 
combination of LPS and alum for 24  h. The control cells were 
left unstimulated. Cells stimulated with LPS and alum together 
for 24  h secreted high concentrations of IL-1β (Figure  3A). 
Moreover, PBMCs from 10 of 17 animals secreted IL-1β when 
incubated with alum in the absence of LPS (Figure 3A).
FigUre 2 | Calcium phosphate and aluminum phosphate adjuvants 
enhance IL-1β secretion by bovine peripheral blood mononuclear cells 
(PBMCs). Cells (0.625 × 106 cells/ml) from three animals were stimulated 
with RPMI, LPS, and/or calcium phosphate (a) or aluminum phosphate  
(B) for 24 h and supernatants were tested for IL-1β using ELISA. PBMCs 
were primed with LPS (10 ng/ml) for 3 h before cells were stimulated with 
adjuvants over a range of concentrations for 24 h. For ELISA analysis, results 
are mean cytokine concentrations (+SEM) in supernatants that were tested 
individually in triplicate. *p < 0.05 and **p < 0.01 were calculated using 
GraphPad.
4
Harte et al. Alum Activates the Bovine NLRP3 Inflammasome
Frontiers in Immunology | www.frontiersin.org November 2017 | Volume 8 | Article 1494
To address whether this response was bovine specific, 
PBMCs from 12 humans were isolated and treated with LPS 
(100  pg/ml) and alum (50  µg/ml). In contrast to the findings 
with bovine PBMCs there was no detectable secretion of IL-1β 
by human PBMCs following incubation with alum when LPS 
was absent (Figure 3B). However, in response to LPS and alum 
combined, human PBMCs secreted high concentrations of IL-1β 
(Figure 3B).
To determine whether alum drives the expression of pro-IL-1β 
as well as IL-1β secretion, PBMCs were isolated from 8 calves and 
cultured in the presence or absence of LPS and/or alum for 6 h. 
The 31 kDa pro-IL-1β band was detected in cells stimulated with 
LPS (Figure 3C). Interestingly, in four of the eight animals tested, 
pro-IL-1β was also present in unstimulated cells thus suggesting 
that some bovine monocular cells are already primed to secrete 
IL-1β (Figure 3C).
alum-induced il-1β secretion in Bovine 
PBMcs is caspase-1 Dependent
In humans, it has been demonstrated that alum-mediated IL-1β 
secretion is caspase-1 dependent (8). Conversely, although alum 
has been incorporated into numerous veterinary vaccines, its 
signaling capacity in a bovine context remains unknown. As a 
result, the role of caspase-1 in alum-induced bovine IL-1β secre-
tion was next investigated.
When bovine PBMCs were incubated with a caspase-1 inhibi-
tor, Z-YVAD-FMK (10 µm), prior to addition of alum, and after 
stimulation with LPS, a substantial reduction in IL-1β secretion 
was observed (Figure  4A). To further prove that caspase-1 is 
involved in alum-induced IL-1β secretion, cells from four ani-
mals were stimulated with cRPMI or alum. Activated caspase-1 
was detected using a caspase-1 detection probe termed FLICA 
660-YVAD-FMK. This probe is comprised of an affinity peptide 
sequence specific for caspase-1 (YVAD), a far-red fluorescent 
660 dye and a fluoromethyl ketone reactive moiety. This reagent 
enters cells and irreversibly binds to active caspase-1 thereby 
emitting and retaining the red signal inside cells positive for 
caspase-1. The results were subsequently analyzed by flow 
cytometry. The results demonstrate that the percentage of cells 
positive for caspase-1 activity is increased in response to alum 
(Figure 4B).
alum-induced il-1β secretion  
in Bovine PBMcs is nlrP3 and  
caspase-8 Dependent
In mice, it has been demonstrated that alum-mediated IL-1β 
secretion is NLRP3 dependent (14, 17). The role of caspase-8 in 
alum-induced IL-1β responses has received less attention. Recent 
publications have indicated that in response to TLR4 activation, 
caspase-8 is required for NLRP3 inflammasome-dependent 
IL-1β processing in murine cells (18). The role of NLRP3 and 
caspase-8 in alum-induced bovine IL-1β secretion has not been 
previously investigated.
Having established that alum-induced IL-1β secretion was 
caspase-1 dependent in bovine cells, the potential role of the 
NLRP3 inflammasome was addressed. LPS-primed PBMCs 
were pretreated with MCC950, a specific NLRP3 inflammasome 
inhibitor (19), prior to the addition of alum. After 24  h the 
supernatants were analyzed by ELISA for IL-1β secretion. LPS 
and alum stimulation induced significantly less IL-1β secretion 
from cells cocultured with 500 nM MCC950 (Figure 5A). In the 
presence of 100, 50, 10, and 1  nM of MCC950, alum-induced 
IL-1β secretion was not abrogated (Figure 5A).
FigUre 3 | A subset of bovine, but not human, peripheral blood 
mononuclear cells (PBMCs) contain preformed IL-1β. Bovine PBMCs from 17 
Friesian cows were stimulated with LPS (100 pg/ml) and alum (50 µg/ml) for 
24 h and tested for IL-1β secretion by ELISA (a). PBMCs from 12 human 
donors were treated with LPS (100 pg/ml) and alum (50 µg/ml) and tested for 
IL-1β using ELISA (B). Bovine cells (2 × 106 cells/ml) from eight cows were 
left unstimulated or treated with LPS and or/alum for 6 h and analyzed by 
western blot for pro-IL-1β (c). For ELISA analysis, results are mean cytokine 
concentrations (+SEM) in supernatants that were tested individually in 
triplicate. *p < 0.05, **p < 0.01, ***p < 0.001 were calculated using 
GraphPad.
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To determine whether alum-induced IL-1β secretion is 
caspase-8 dependent, LPS-primed PBMCs were incubated with 
Z-IETD-FMK, a caspase-8 inhibitor, after which they were 
cocultured with alum for 24 h. IL-1β secretion was suppressed by 
caspase-8 inhibition after 24 h (Figure 5B). These data suggest 
that caspase-8 and caspase-1 both contributed to alum-induced 
IL-1β secretion by bovine PBMCs.
alum Promotes asc Oligomerization
Inflammasome activation involves NLRP3 recruiting and bind-
ing to the adaptor protein ASC through interactions involving the 
PYD domain on both molecules (20). When bound to NLRP3, 
ASC oligomerizes to form a pyroptosome which then binds to 
pro-caspase-1 via homotypic interactions (21). The assembled 
inflammasome facilitates the cleavage and activation of cas-
pase-1, which cleaves pro-IL-1β to its bioactive form resulting 
in its secretion from the cell (21, 22). In murine models, it has 
been demonstrated that ASC oligomerization is crucial for the 
activation of caspase-1 (22–24).
To assess the effects of alum on ASC oligomerization in bovine 
cells, PBMCs were cultured at a density of 107 /ml. Cells were left 
unstimulated, treated with LPS (100 pg/ml), alum (50 µg/ml), or 
a combination of both for 3 h. Afterward, the cells were lysed and 
probed for ASC oligomerization by western blotting. In response 
to alum alone or together with LPS, the oligomerization of ASC 
was evident by detection of an 80–90 kDa molecular weight band 
(Figure 6; Figure S3 in Supplementary Material). The oligomer 
was absent in unstimulated cells or those incubated with LPS 
alone.
cathepsin activity is required for  
alum-induced il-1β secretion  
from Bovine PBMcs
Studies on murine macrophages and dendritic cells have dem-
onstrated that alum induces lysosomal disruption resulting in 
activation of the NLRP3 inflammasome (25, 26). Additionally, 
lysosomal damage and release of hydrolases has been shown to 
up-regulate caspase-1 activity (27). To determine whether lyso-
somal proteases play a role in regulating bovine IL-1β secretion, 
PBMCs were cultured for 1 h with an inhibitor (CA-074-Me) tar-
geting cathepsin B, a protease released during lysosomal damage. 
Following that, the cells were stimulated with alum (50 µg/ml) for 
24 h after which the supernatants were collected and tested for 
IL-1β. Cells stimulated with LPS and alum produced substantially 
less IL-1β when incubated in the presence of the cathepsin B 
inhibitor than those cultured without the inhibitor (Figure 7A). 
Since at high concentrations this inhibitor can also inhibit other 
lysosomal cysteine cathepsins (28), we confirmed these results 
with CA-074 which although less cell permeable than CA-074-Me, 
has been shown to have enhanced selectivity for cathepsin B (28) 
(Figure 7B). CA074 inhibited alum-induced IL-1β secretion at 
a concentration of 50 µM. Finally to confirm that alum results 
in lysosomal damage, we stained cells with calcein. Calcein is 
endocytosed by cells in a non-specific manner, but cannot diffuse 
across endosomal membranes. This leads to calcein becoming 
FigUre 4 | Alum-induced IL-1β secretion is caspase-1 dependent. LPS (100 pg/ml)-primed cells from three animals were incubated with Z-YVAD-FMK (10 µM) for 
40 min. Following this, the cells were stimulated with alum (50 µg/ml) for 24 h and supernatants were then harvested and analyzed by ELISA for IL-1β (a). Cells were 
seeded (1.5 × 106) and treated with LPS and alum for 2 h. Following this, the cells were analyzed by flow cytometry to assay for caspase-1 (B). The data are 
representative of four animals (<1 year old) (B). For ELISA analysis, results are mean cytokine concentrations (+SEM) in supernatants that were tested individually in 
triplicate. *p < 0.05, **p < 0.01, ***p < 0.001 were calculated using GraphPad.
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trapped in endosomes resulting in a “punctate” staining pattern 
(13), as observed when bovine PBMCs are cotreated with RPMI 
or LPS in Figure 7C. However, when taken up by PBMCs that 
have been costimulated with alum, calcein homogenously stains 
the entire cell as a result of alum-driven lysosomal disruption and 
subsequent leakage of lysosomal contents (including calcein) into 
the cell cytoplasm.
DiscUssiOn
Inflammasomes are key intracellular signaling components 
that regulate immunity through activating caspase-1, which 
subsequently leads to the processing of the cytokines IL-1β and 
IL-18. It has been demonstrated that IL-1β is a key regulator of 
T-cell cytokine production, can restrict bacterial replication in 
macrophages (29), and recruits neutrophils to the site of infection 
(30–33). Although inflammasome activation has been implicated 
as an important component of the bovine immune response to 
pathogens, including mycobacteria (34), the detailed mecha-
nisms of inflammasome activation in a bovine context have not 
been addressed.
Given the distinct evolutionary differences between species, 
mechanistic understanding from human and murine studies 
cannot be assumed to apply in other species, including cattle. For 
example, in contrast to humans and mice, genes that encode DNA 
sensing inflammasome-associated proteins like the Pyrin and 
Hin domain family are Pseudogenised in some mammals includ-
ing cattle (35). This suggests that these mammals have evolved 
FigUre 6 | Alum promotes the oligomerization of ASC. Cells (10 × 106) 
were pretreated with LPS 3 h before alum was administered. Cell lysates 
were harvested 3 h later and ASC oligomers (80–90 kDa) were detected 
through western blotting. The data are representative of two animals aged 
<6 months old.
FigUre 5 | Alum-induced IL-1β secretion is NLRP3 and caspase-8 dependent. LPS (100 pg/ml)-primed cells from three animals were incubated with MCC950 
(500, 100, 50, 10, and 1 nM) (a) and Z-IETD-FMK (10 µm) (B). After 40 min, the cells were stimulated with alum (50 µg/ml) for 24 h and supernatants were then 
harvested and analyzed by ELISA for IL-1β. For ELISA analysis, results are mean cytokine concentrations (+SEM) in supernatants that were tested individually in 
triplicate. *p < 0.05, **p < 0.01, ***p < 0.001 were calculated using GraphPad.
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alternate mechanisms to cope with DNA viruses. Species-specific 
investigations are therefore warranted, particularly in order to 
enhance the efficacy of novel vaccination strategies (36).
In accordance with observations made in murine and human 
studies, results from this study demonstrate that alum enhances 
IL-1β secretion from bovine PBMCs. Surprisingly, in the absence 
of LPS, alum was sufficient for promoting IL-1β secretion from 
PBMCs in a subset of animals, a result in contrast to what is 
observed in murine and human macrophages (14, 37). These 
results show for the first time that IL-1β activation in PBMCs 
from a subset of animals is not solely dependent on LPS stimula-
tion and that a subset of Friesian cattle have primed cells capable 
of secreting IL-1β in response to alum alone. Moreover, this was 
not seen in human PBMCs suggesting a bovine-specific response.
The intracellular processes underlying alum-induced IL-1β 
secretion were investigated, using inflammasome-specific 
inhibitors in cell culture. In mice, loss of NLRP3 and caspase-1 
abrogates alum-induced IL-1β secretion in vitro, while a role for 
caspase-8 has also been proposed (8, 17). Consistent with what has 
been recorded in mice, alum-induced IL-1β secretion in bovine 
PBMCs is NLRP3 and caspase-1 dependent. Furthermore, results 
obtained using the FLICA assay confirm that alum can promote 
the activation of caspase-1 in bovine PBMCs. Unexpectedly, 
results from the FLICA assay showed that unstimulated PBMCs 
expressed active caspase-1. However, published data from Netea 
et al showed that caspase-1 was active in untreated human mono-
cytes but not in macrophages (38). Alum-induced IL-1β secretion 
was reduced when caspase-8 was inhibited, thus suggesting that 
both caspase-1 and caspase-8 play roles in this process. From this 
study, it has been proposed that alum promotes IL-1β secretion by 
initiating the assembly of the NLRP3 inflammasome as outlined 
in Figure 8.
This research also established that alum promotes ASC oli-
gomerization in bovine PBMCs. ASC mediates the interaction 
between NLRP3 and caspase-1, which ultimately leads to the for-
mation of the inflammasome complex (39). Several studies have 
demonstrated that the oligomerization of ASC is key to NLRP3 
inflammasome activation (22, 23), but this had not previously 
been addressed in bovine cells. Data from studies on human cells 
indicate that the ASC monomer is 22 kDa, while the oligomer 
is approximately 80–90  kDa (40, 41). In the current study, the 
size of the alum-induced ASC oligomers corresponds to what 
was recorded in humans. Similarly, in accordance with murine 
studies, these data also demonstrate that alum leads to lysosomal 
degradation and subsequent cathepsin release, which ultimately 
leads to the activation of the inflammasome in bovine PBMCs. 
It has been reported that cathepsin B mediates the activation of 
NLRP3 and caspase-1 leading to the secretion of processed IL-1β 
in mice (42–44).
To ensure the effectiveness of novel vaccine formulations, 
antigenicity has to be combined with adjuvanticity. Recent 
moves toward subunit vaccines yields higher specificity but with 
a requirement for effective adjuvants to activate and direct innate 
immunity and enhance immunogenicity (45). Although the 
role of alum in activating the inflammasome in mice has been 
FigUre 8 | Proposed mechanism of alum-induced IL-1β secretion from bovine peripheral blood mononuclear cells (PBMCs). Alum enters the cell and induces 
lysosomal degradation to release cathepsins. From murine studies, it is proposed that cathepsin B can drive NLRP3 activation, which then mediates ASC 
oligomerization and caspase-1 and/or caspase-8 activation. These responses lead to the secretion of processed IL-1β from bovine PBMCs.
FigUre 7 | Alum induces lysosomal disruption and inhibition of lysosomal cathepsin B reduces alum-induced IL-1β secretion in bovine peripheral blood 
mononuclear cells (PBMCs). Bovine PBMCs from three animals were seeded and stimulated with LPS (100 pg/ml). Cells were then incubated with CA-074Me (a) or 
CA-074 (B) prior to stimulation with alum (50 µg/ml). Supernatants were collected after 24 h and IL-1β concentrations were detected by ELISA. (c) PBMCs treated 
with medium, LPS or alum were incubated with calcein for 3hr and visualized by confocal microscopy. For ELISA analysis, results are mean cytokine concentrations 
(+SEM) in supernatants that were tested individually in triplicate. *p < 0.05, **p < 0.01, ***p < 0.001 were calculated using GraphPad.
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well documented, its mechanism of action in cattle PBMCs was 
previously unclear. Given that alum has been incorporated into 
numerous bovine vaccine formulations, such as those against 
Leptospirosis, BVDV and Blue tongue virus, investigation of its 
mode of action in bovine PBMCs is important to facilitate more 
rational vaccine design. It will be important in future to address 
the role of the inflammasome in vaccine efficacy in a bovine 
context in vivo as there are conflicting reports from murine stud-
ies regarding the role of the NLRP3 inflammasome in driving 
adaptive immunity, particularly antibody responses (6, 46). The 
current data will inform future studies and aid the design of novel 
bovine vaccines aimed at targeting the inflammasome. As well as 
playing key roles in antigen presenting cells, inflammasome acti-
vation in epithelial cells could also be of significant importance 
in response to bovine mucosal vaccines.
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